# Treatment of Rectal Cancer With Long-term Concurrent Chemoradiotherapy Combined With Camrelizumab

Source: https://onco.cc/trials/nct06304545/  
OnCo record `nct06304545` (Trial). Data CC BY-NC 4.0, attribute "Data from OnCo (onco.cc)"; commercial use needs a licence.

## TL;DR

A phase 2 trial of camrelizumab in colorectal cancer, run by Harbin Medical University, not yet recruiting.

## Summary

Treatment of Rectal Cancer With Long-term Concurrent Chemoradiotherapy Combined With Camrelizumab is a phase 2, interventional study registered as NCT06304545 by Harbin Medical University, with a registry enrolment figure of 48 participants, started 2024-03-15 and due to reach its primary completion in 2026-08-16. Interventions recorded: Camrelizumab; Chemotherapy; Radiotherapy. Conditions listed: Rectal Cancer. Primary outcome: Pathological Complete Response rate. Colorectal eligibility wording from the registry: "Histologically or cytologically confirmed rectal cancer with measurable tumour lesions (Spiral CT or MR scans ≥ 10 mm, meeting RECIST 1". No results are recorded here; the registry entry is the source.

## Fields

- Kind: Trial
- Status: planned
- Last checked: 2026-09-24
- Tags: ctgov-ingest; colorectal-deep-dive
- Registry id: NCT06304545
- Phase: 2
- Setting: Long-course Concurrent Chemoradiotherapy Combined With Camrelizumab in the Neoadjuvant Treatment of Locally Advanced/Low Anus-preserving Rectal Cancer: a Phase II Single-arm Study.
- Sponsor: Harbin Medical University
- Enrolled: 48

## Sources

- ClinicalTrials.gov NCT06304545: https://clinicaltrials.gov/study/NCT06304545

## Connected records

- cancers: [Rectal cancer](https://onco.cc/cancers/rectal-cancer/)
- technologies: [Immune checkpoint inhibitors](https://onco.cc/technologies/checkpoint-inhibitor/), [IMRT / IGRT (modern external beam)](https://onco.cc/technologies/imrt-igrt/)
- drugs: [Camrelizumab](https://onco.cc/drugs/camrelizumab/)
- terms: [Colorectal cancer trials open today (registry snapshot)](https://onco.cc/terms/colorectal-trials-open-today/)

---
JSON: https://onco.cc/api/v1/entities/nct06304545.json